Compare
BIO vs TMO vs DHR vs A
Up to five stocks or ETFs side by side. Performance is rebased to 100 at the start of the window.
Relative performance
| BIO | TMO | DHR | A | |
|---|---|---|---|---|
| Price | $381.57 | $694.76 | $230.25 | $174.76 |
| 1-day | +3.41% | +2.63% | +1.73% | +1.73% |
| YTD | +25.93% | +19.90% | +0.58% | +28.43% |
| 1 year | +23.08% | +22.39% | +8.50% | +19.07% |
| 3 years | +37.50% | +57.50% | +21.18% | +69.90% |
| Market cap | $10.3B | $257.4B | $162.0B | $49.3B |
| P/E | 10.1 | 36.6 | 37.7 | 34.5 |
| P/S | 3.97 | 5.44 | 6.33 | 6.68 |
| P/B | 1.35 | 4.70 | 3.02 | 6.69 |
| Revenue growth | +1.40% | +8.30% | +5.50% | +8.60% |
| EPS growth | — | +9.50% | +26.00% | +18.70% |
| Gross margin % | 51.3 | 25.2 | 58.6 | 53.8 |
| Net margin % | 39.5 | 14.9 | 16.9 | 19.5 |
| ROE % | 13.5 | 12.9 | 8.1 | 19.6 |
| Debt / equity | 0.11 | 0.79 | 0.49 | 0.54 |
| FCF yield % | 3.2 | 3.0 | 3.5 | 2.6 |
| Dividend yield % | — | 0.26 | 0.66 | 0.58 |
| Beta | 0.75 | 0.67 | 0.53 | 0.89 |
| RSI (14) | 56.1 | 54.7 | 53.5 | 53.2 |
| Technical rating |